The story of AstraZeneca's adventures in vaccines and politics is impossible to separate from the background of the man in charge. As one of his competitors put it: "Astra is Pascal's company ...

However, it is uncertain what the background rate of these blood clots ... Instead nearly 90% of Germans given AstraZeneca are thought to be under 60. Side-effects in general tend to be more ...

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...

The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities ...

AscellaHealth has announced significant additions to its executive team with the promotion of Gillian Molloy to Vice ...

AstraZeneca and Ionis Pharmaceuticals are also teamed up ... Alnylam tested vutrisiran in patients receiving background ...

A large chunk of the fund’s assets (often 20% or more) sits in biotech and pharma stocks, including its biggest four holdings, Eli Lilly LLY, AstraZeneca ... an investing background so that ...

Today, Governor Jeff Landry announced the appointment of Misti Cordell as Chairwoman of the Louisiana Board of Regents. Misti was appointed to the board in January as an at-large member.

Roche has now beat Merck and Bristol Myers to market with its under-the-skin immunotherapy. Elsewhere, Sanofi bought into ...

AstraZeneca, Cambridge, UK Background Mucus plugs are associated with airway inflammation and obstruction in patients with asthma. The impact of treatment on mucus plugs has not been investigated in ...

Background Angiopoietin (Ang)-1 and Ang-2 ... Competing interests MF is an employee of AstraZeneca. BN, WI, JRC, MAS and AJC are employees of MedImmune Ltd., a wholly owned subsidiary of AstraZeneca.

Background EULAR recommendations for treatment for Systemic ... Grant/research support from: Abbvie, AstraZeneca, Boheringer-Ingelheim, Capella, Chemomab, Kymab, Janssen, Mitsubishi-Tanabe, Alain ...